The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.
Ki Won LeeSeyeon LimKwang Dong KimPublished in: International journal of molecular sciences (2022)
N-myc downstream-regulated gene 2 (NDRG2) is a tumor-suppressor gene that suppresses tumorigenesis and metastasis of tumors and increases sensitivity to anti-cancer drugs. In this review, we summarize information on the clinicopathological characteristics of tumor patients according to NDRG2 expression in various tumor tissues and provide information on the metastasis inhibition-related cell signaling modulation by NDRG2. Loss of NDRG2 expression is a prognostic factor that correlates with TNM grade and tumor metastasis and has an inverse relationship with patient survival in various tumor patients. NDRG2 inhibits cell signaling, such as AKT-, NF-κB-, STAT3-, and TGF-β-mediated signaling, to induce tumor metastasis, and induces activation of GSK-3β which has anti-tumor effects. Although NDRG2 operates as an adaptor protein to mediate the interaction between kinases and phosphatases, which is essential in regulating cell signaling related to tumor metastasis, the molecular mechanism of NDRG2 as an adapter protein does not seem to be fully elucidated. This review aims to assist the research design regarding NDRG2 function as an adaptor protein and suggests NDRG2 as a molecular target to inhibit tumor metastasis and improve the prognosis in tumor patients.
Keyphrases
- prognostic factors
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- cell therapy
- single cell
- signaling pathway
- ejection fraction
- transcription factor
- gene expression
- stem cells
- cell proliferation
- healthcare
- genome wide
- epithelial mesenchymal transition
- binding protein
- immune response
- copy number
- patient reported
- patient reported outcomes
- dna methylation
- mesenchymal stem cells
- transforming growth factor
- single molecule
- genome wide analysis